Trial
NCT04872608
A Study of Letrozole, Palbociclib, and Onapristone ER in People With Metastatic Breast Cancer
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
Context Therapeutics Inc.
Condition
Metastatic Breast Cancer
Intervention
Letrozole
Why stopped
The sponsor closed the study due to discontinuing their onapristone program
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-04-28